Cervical cancer is the second most common cancer in women worldwide, and knowledge
regarding its cause and pathogenesis is expanding rapidly. Persistent infection with one of …

Traditional EPI vaccines are considered to be among the most efficient uses of scarce health
care resources. Today, there are many under-used and new vaccines available. In the short …

Background The cost-effectiveness of prophylactic vaccination against human
papillomavirus types 16 (HPV-16) and 18 (HPV-18) is an important consideration for …

Objective To assess the cost effectiveness of including preadolescent boys in a routine
human papillomavirus (HPV) vaccination programme for preadolescent girls. Design Cost …

This study assesses knowledge, attitudes, and behavioural intention towards human
papillomavirus (HPV) infection and vaccination in a random sample of 1348 adolescents …

This guide was developed to help meet the need of decision-makers for relevant, reliable
and consistent economic information; it aims to provide clear and concise, practical, high …

Objective To determine the costs and health effects of interventions to combat breast,
cervical, and colorectal cancers in order to guide resource allocation decisions in …

Cost effectiveness is becoming an increasingly important factor for stakeholders faced with
decisions about adding a new vaccine into national immunization programmes versus …

Objectives: One of the two new human papillomavirus (HPV) vaccines protects against HPV
types 6 and 11, which cause over 95% of genital warts, in addition to protecting against HPV …

We assessed the cost-effectiveness of including boys vs girls alone in a pre-adolescent
vaccination programme against human papillomavirus (HPV) types 16 and 18 in Brazil …